Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.65 |
| ▸ | ITGAV | P06756 | 2/20 | 0.65 |
| ▸ | IDO1 | P14902 | 12/20 | 0.59 |
| ▸ | HTR3E | A5X5Y0 | 7/20 | 0.48 |
| ▸ | HTR3B | O95264 | 7/20 | 0.48 |
| ▸ | HTR3A | P46098 | 7/20 | 0.48 |
| ▸ | HTR3D | Q70Z44 | 7/20 | 0.48 |
| ▸ | HTR3C | Q8WXA8 | 7/20 | 0.48 |
| ▸ | TDO2 | P48775 | 2/20 | 0.46 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.39 |
| ▸ | SLC22A3 | O75751 | 2/20 | 0.39 |
| ▸ | PLAU | P00749 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL22263083 | 0.98 | ITGB3 (0.63) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| Nitric Acid SCHEMBL6034257 | 0.75 | ITGB3 (0.60) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| Iodide SCHEMBL3531234 | 0.73 | HTR3E (0.73) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| SCHEMBL20932724 | 0.72 | ITGB3 (0.52) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| SCHEMBL30130150 | 0.72 | ITGB3 (0.52) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| SCHEMBL9342643 | 0.71 | ITGB3 (0.53) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| SCHEMBL9342646 | 0.71 | ITGB3 (0.53) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| Bromide SCHEMBL30130114 | 0.71 | ITGB3 (0.51) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| SCHEMBL20932236 | 0.71 | ITGB3 (0.51) | ITGB3ITGAVIDO1HTR3EHTR3B | |
| SCHEMBL13131511 | 0.70 | IDO1 (0.50) | ITGB3ITGAVIDO1TDO2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200239452-A1 | IDO/TDO Inhibitor | CANBAS CO., LTD. (JP) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239452-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | ITGB3 4678/4885ITGAV 4776/4885IDO1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.